Technology, Science, & Me!: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology, Science, & Me!.

Press releases published on July 15, 2026

Jul. 15, 2026

aTyr Pharma to Present Subgroup Analysis of Phase 3 EFZO-FIT™ Study of Efzofitimod in Pulmonary Sarcoidosis at WASOG 2026

Indeterminate GlobeNewswire

Jul. 15, 2026

Rani Therapeutics Announces Positive Initial Phase 1a Data for RT-114 for the Treatment of Obesity, with Oral Bioavailability Exceeding Matched Subcutaneous Dosing

Indeterminate GlobeNewswire

Jul. 15, 2026

Cardiff Oncology Announces $10 Million Registered Direct Offering

Indeterminate GlobeNewswire

Jul. 15, 2026

GoldHaven Defines District-Scale Structural Corridor at Magno Following Completion and Interpretation of Largest Modern Airborne Survey on the Project

Indeterminate GlobeNewswire

Jul. 15, 2026

Youxin Technology Signs Cooperation Intention Agreement to Join Guangzhou's Citywide Government AI Hub Initiative “SuiZhiZheng” as an Ecosystem Partner

Indeterminate GlobeNewswire

Jul. 15, 2026

UroGen Receives New U.S. Patent Allowance Expected to Provide Protection into July 2044 for ZUSDURI™ and UGN-103

Indeterminate GlobeNewswire

Jul. 15, 2026

Belite Bio to Participate in the H.C. Wainwright 6th Annual Ophthalmology Virtual Conference

Indeterminate GlobeNewswire

Jul. 15, 2026

Genius Group Sets Record Date for Share Loyalty Bonus Program at $0.10 Per Share

Indeterminate GlobeNewswire

Jul. 15, 2026

Skyline Builders Group Holding Adds John M. Melkon to Board of Directors

Indeterminate GlobeNewswire

Jul. 15, 2026

MIRROTO Launches The Social Trading Network, Expanding Access to Copy Trading Across Emerging Markets

Indeterminate GlobeNewswire

Jul. 15, 2026

InnoCare Announces Phase III Study Results of TYK2 Inhibitor Soficitinib Meet Primary Endpoint in Patients with Atomic Dermatitis

Indeterminate GlobeNewswire

Jul. 15, 2026

Ernexa Therapeutics Receives Independent Validation of ERNA-101 with Complete Tumor Clearance and Durable Survival in Ovarian Cancer Models Ahead of Planned Clinical Entry

Indeterminate GlobeNewswire

Jul. 15, 2026

NEVGOLD ANNOUNCES MINERAL RESOURCE: ANTIMONY OF 29,600 TONNES MEASURED & INDICATED (0.26%) AND 48,100 TONNES INFERRED (0.18%); 100% OXIDE GOLD OF 181,400 OZS MEASURED & INDICATED AND 1,203,500 OZS INFERRED; STRATEGIC U.S. ANTIMONY RESOURCE

Indeterminate GlobeNewswire

Jul. 15, 2026

Gildan Activewear Announces Date for Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Jul. 15, 2026

Les Vêtements de Sport Gildan annonce la date de publication de ses résultats financiers du deuxième trimestre de 2026

Indeterminate GlobeNewswire

Jul. 15, 2026

CCTE's ANEEL Fuel Published in Leading Peer-Reviewed Journal, Building on Completed High-Burnup Irradiation at Idaho National Laboratory

Indeterminate GlobeNewswire

Jul. 15, 2026

Cellectar Biosciences Announces Publication of Phase 1 Study of Iopofosine I 131 in Peer-Reviewed Journal Cancers

Indeterminate GlobeNewswire

Jul. 15, 2026

TappAlpha Expands Growth + Income ETF Platform with TMGN, Bringing Tax-Efficient Income to the Cboe Magnificent 10 Index

Indeterminate GlobeNewswire

Jul. 15, 2026

Repligen to Report Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Jul. 15, 2026

Senti Biosciences Holdings, Inc. Announces a Strategic Transaction to Unlock Value for its Gene-Circuit-Enabled Pipeline, Including SENTI-202, and to Sharpen its Focus on Next-Generation Controllable Genetic Medicines Powered by its Regulator Dial™…

Indeterminate GlobeNewswire